| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €24,8067 | +4,21% | €1,50B | €122,77K | |
SGRY Surgery Partners, Inc. Common Stock | €11,8637 | +2,11% | €1,50B | €326,56K | |
GAB The Gabelli Equity Trust Inc. | €4,8203 | -0,09% | €1,50B | €503,41K | |
HURN Huron Consulting Group Inc. | €92,0174 | +2,09% | €1,49B | €27,00K | |
ENVX Enovix Corporation Common Stock | €7,1518 | +1,05% | €1,49B | €2,62M | |
PAYO Payoneer Global Inc. Common Stock | €4,4763 | +2,26% | €1,49B | €953,45K | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12,8441 | +0,17% | €1,49B | €75,53K | |
STGW Stagwell Inc. Class A Common Stock | €5,7921 | +2,20% | €1,49B | €266,40K | |
CASH Pathward Financial, Inc. Common Stock | €67,9615 | +1,65% | €1,49B | €54,33K | |
SNDX Syndax Pharmaceuticals, Inc. | €15,4121 | -2,28% | €1,49B | €3,85M | |
STRA Strategic Education, Inc. Common Stock | €70,1201 | +3,14% | €1,49B | €58,24K | |
CAPR Capricor Therapeutics Inc | €24,3285 | +2,35% | €1,49B | €188,06K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15,8412 | +3,08% | €1,48B | €1,48K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,6239 | +8,24% | €1,48B | €3,00M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €23,6887 | +10,22% | €1,48B | €240,68K | |
